+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Genomic Cancer Panel and Profiling Markets by Cancer, by Application, by Tissue and by Gene Type With Screening Potential Market Size, Customized Forecasting/Analysis, and Executive and Consultant Guides 2022-2026

  • PDF Icon

    Report

  • 576 Pages
  • August 2022
  • Region: Global
  • Howe Sound Research
  • ID: 5354570

Cancer diagnosis and treatment is entering a new Large Profile Panels are dominating the market. Clinicians and Pharmaceutical customers building global demand and a new diagnostic industry based on Cancer Gene Sequencing. What role will Whole Genome Sequencing eventually play?

Cancer Gene Panels and Genomic Profiling are quickly changing the diagnosis and treatment of cancers. The market is moving out of a specialized niche and going mainstream as Oncologists begin routinely using information on the hundreds of genes related to cancer. The market is exploding as physicians use all the information they can get in the battle against cancer. While Pharmaceutical Companies see the potential to make nearly any therapy viable. The report has data on how test volumes have grown for the biggest players. Find out how this new way of understanding cancer will change cancer diagnostics forever.

Comprehensive panels, genomic profiling, high risk breast cancer panels. Learn all about how players are jockeying for position in a market that is being created from scratch. And some players are pulling way out in front and expanding globally. It is a dynamic market situation with enormous opportunity where the right diagnostic with the right support can command premium pricing. And the science is developing at the same time creating new opportunities with regularity. And the cost of sequencing continues to fall. 

Genomic Cancer Panel and Profiling Markets by Cancer, by Application, by Tissue and by Gene Type with Screening potential market size, customized forecasting/analysis,
and Executive and Consultant Guides 2022-2026 provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2022 United States Medicare Fee Payment Schedules to help understand the new pricing for cancer panels. Forecast demand for new testing regimes or technologies. Make research investment decisions. Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges. 

The report includes detailed breakouts for 18 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

Table of Contents

1 Market Guides
1.1 Cancer Panel Market - Strategic Situation Analysis & COVID Update
1.2 Large Comprehensive Cancer Panel Market - Situation Analysis
1.3 Guide for Executives, Marketing, Sales and Business Development Staff
1.4 Guide for Management Consultants and Investment Advisors
1.5 Market Size and Shares - Large Comprehensive
2 Introduction and Market Definition
2.1 What are Cancer Gene Panels and Profiling?
2.2 The Sequencing Revolution
2.3 Market Definition
2.3.1 Revenue Market Size
2.4 Methodology
2.4.1 Authors
2.4.2 Sources
2.5 Perspective: Healthcare and the IVD Industry
2.5.1 Global Healthcare Spending
2.5.2 Spending on Diagnostics
2.5.3 Important Role of Insurance for Diagnostics
3 Market Overview
3.1 Players in a Dynamic Market
3.1.1 Academic Research Lab
3.1.2 Diagnostic Test Developer
3.1.3 Instrumentation Supplier
3.1.4 Distributor and Reagent Supplier
3.1.5 Independent Testing Lab
3.1.6 Public National/regional lab
3.1.7 Hospital lab
3.1.8 Physician Office Labs
3.1.9 Audit Body
3.1.10 Certification Body
3.2 Oncogenomics
3.2.1 Carcinogenesis
3.2.2 Chromosomes, Genes and Epigenetics
3.2.2.1 Chromosomes
3.2.2.2 Genes
3.2.2.3 Epigenetics
3.2.3 Cancer Genes
3.2.4 Germline vs Somatic
3.2.5 Gene Panels, Single Gene Assays and Multiplexing
3.2.6 Genomic Profiling
3.2.7 The Comprehensive Assay
3.2.8 Changing Clinical Role
3.2.9 The Cancer Screening Market Opportunity
3.3 Cancer Management vs. Diagnosis
3.3.1 The Role of Risk Assessment
3.3.2 Diagnosis
3.3.3 Managing
3.3.4 Monitoring
3.4 Phases of Adoption - Looking into The Future
3.5 Structure of Industry Plays a Part
3.5.1 Hospital Testing Share
3.5.2 Economies of Scale
3.5.2.1 Hospital vs. Central Lab
3.5.3 Physician Office Lab’s
3.5.4 Physician’s and POCT
3.6 Currently Available Large Comprehensive Assays
3.7 Pricing Profiling vs. Whole Exome (or Genome) Sequencing
3.7.1 Medicare Profile Pricing
3.7.2 Whole Exome Sequencing
4 Market Trends
4.1 Factors Driving Growth
4.1.1 Level of Care
4.1.2 Companion Dx
4.1.3 Immuno-oncology
4.1.4 Liability
4.1.5 Aging Population
4.2 Factors Limiting Growth
4.2.1 State of knowledge
4.2.2 Genetic Blizzard
4.2.3 Protocol Resistance
4.2.4 Regulation and coverage
4.3 Instrumentation and Automation
4.3.1 Instruments Key to Market Share
4.3.2 Bioinformatics Plays a Role
4.4 Diagnostic Technology Development
4.4.1 Next Generation Sequencing Fuels a Revolution
4.4.2 Single Cell Genomics Changes the Picture
4.4.3 Pharmacogenomics Blurs Diagnosis and Treatment
4.4.4 CGES Testing, A Brave New World
4.4.5 Biochips/Giant magneto resistance based assay
5 Cancer Panels & Profiles Recent Developments
5.1 Recent Developments - Importance and How to Use This Section
5.1.1 Importance of These Developments
5.1.2 How to Use This Section
5.2 Genetron Health Adds New Assays to Pipeline
5.3 Illumina Obtains CE-IVD Marking for TSO Comprehensive Assay
5.4 Guardant Health Receives Medicare Coverage for Guardant360 TissueNext™ Test
5.5 Cancer Screening Launch Approaches, Guardant Health Plans New Comprehensive Assay
5.6 Thermo Fisher, Oncocyte Ink Deal for Cancer IVDs
5.7 Local Cancer Genomic Profiling Options Grow, Though Central Labs Will Likely Keep Major Role
5.8 Labcorp, CCORN Partner for Precision Oncology
5.9 Dante Labs Acquires Cambridge Cancer Genomics
5.10 Celemics, Strand Partner on Integrated Platform for NGS Analysis
5.11 Myriad Genetics Recalibrates Breast Cancer Panel for All Ancestries
5.12 Burning Rock Revenues Rise
5.13 Caris Life Sciences to Expand Liquid Biopsy Testing
5.14 OncoDiag Announces Multiplex Test for Bladder Cancer Recurrence
5.15 Intermountain and Myriad Combine Test Offering
5.16 Illumina, Geneseeq to Offer Cancer Testing Kits in China
5.17 Exact Sciences to Offer End-to-End Cancer Testing
5.18 Guardant Health Turns to Tumor Tissue Sequencing
5.19 Tempus Inks Oncology Testing Collaboration With Bayer
5.20 Biocartis Collaborating With GeneproDx, Endpoint Health on Tests for Idylla Platform
5.21 Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test
5.22 Metastatic Cancer Markers Identified in Clinical WGS Study
5.23 Stitch Bio Bets on CRISPR Tech
5.24 Bayer, LifeLabs Launch Free NTRK Genetic Testing Program
5.25 Foundation Medicine Liquid Biopsy Gets FDA Approval for Multiple Companion Dx
5.26 Progress, Challenges in Liquid Biopsy Reimbursement
5.27 Israeli Startup Curesponse Raises $6M
5.28 Invitae, ArcherDX Merge to Advance Precision Oncology Offerings
5.29 MD Anderson Precision Oncology Decision Support to Use Philips' Informatics Solution
5.30 NeoGenomics, Lilly Oncology Partner for Thyroid Cancer Testing Program
5.31 Germline Results Guides Precision Therapy in Advanced Cancer
5.32 FDA Clears Cancer Genomic Profiling Kit From Personal Genome Diagnostics
5.33 ArcherDX, Premier Collaborate to Evaluate Genomic Sequencing Assay for Cancers
5.34 Labs Reporting Cancer Risk Mutations from Tumor Testing
5.35 Users Begin Integrating Genomics Data for Clinical Decision Support
5.36 Fujitsu Improves Efficiency in Cancer Genomic Medicine
5.37 Thermo Fisher's automated sequencer to offer same-day, pan-cancer test results
5.38 Universal Genetic Testing for All Breast Cancer Patients
5.39 Exact Sciences buys Genomic Health
5.40 Multi-Gene Liquid Biopsy Breast Cancer Panel
5.41 Thrive to Develop Earlier Detection of Multiple Cancer Types
5.42 New Gene Panel Identifies High Risk Prostate Cancer
5.43 Guardant Health Liquid Biopsy Test to be Covered by EviCore
5.44 Biocept Partnership Offering for Liquid Biopsy Adds Several Key Services
5.45 Natera Commercializes Tumor Whole Exome Sequencing from Plasma
5.46 Bio-Rad Clinical ddPCR Test, Diagnostic System Get FDA Clearance
6 Profiles of Key Players
6.1 10x Genomics, Inc.
6.2 Abbott Diagnostics
6.3 AccuraGen Inc.
6.4 Adaptive Biotechnologies
6.5 Aethlon Medical
6.6 Agena Bioscience, Inc.
6.7 Agilent/Dako
6.8 Anchor Dx
6.9 ANGLE plc
6.10 ApoCell, Inc.
6.11 ArcherDx, Inc.
6.12 ARUP Laboratories
6.13 Asuragen
6.14 AVIVA Biosciences
6.15 Baylor Miraca Genetics Laboratories
6.16 Beckman Coulter Diagnostics
6.17 Becton, Dickinson and Company
6.18 BGI Genomics Co. Ltd
6.19 Bioarray Genetics
6.20 Biocartis
6.21 Biocept, Inc
6.22 Biodesix Inc
6.23 BioFluidica
6.24 BioGenex
6.25 BioIVT
6.26 Biolidics Ltd
6.27 bioMérieux Diagnostics
6.28 Bioneer Corporation
6.29 Bio-Rad Laboratories, Inc
6.30 Bio-Reference Laboratories
6.31 Bio-Techne
6.32 Bioview
6.33 Bolidics
6.34 Boreal Genomics
6.35 Bristol-Myers Squibb
6.36 Burning Rock
6.37 Cancer Genetics
6.38 Caris Molecular Diagnostics
6.39 Castle Biosciences, Inc.
6.40 Celemics
6.41 CellMax Life
6.42 Cepheid (Danaher)
6.43 Charles River Laboratories
6.44 Chronix Biomedical
6.45 Circulogene
6.46 Clinical Genomics
6.47 Cynvenio
6.48 Cytolumina Technologies Corp.
6.49 CytoTrack
6.50 Datar Cancer Genetics Limited
6.51 Diagnologix LLC
6.52 Diasorin S.p.A.
6.53 Enzo Life Sciences, Inc
6.54 Epic Sciences
6.55 Epigenomics AG
6.56 Eurofins Scientific
6.57 Exact Sciences
6.58 Exosome Diagnostics
6.59 Exosome Sciences
6.60 Fabric Genomics
6.61 Fluidigm Corp
6.62 Fluxion Biosciences
6.63 Foundation Medicine
6.64 Freenome
6.65 FUJIFILM Wako Diagnostics
6.66 GeneFirst Ltd
6.67 Genetron Holdings
6.68 GenomOncology
6.69 GILUPI Nanomedizin
6.70 Grail, Inc.
6.71 Guardant Health
6.72 HalioDx
6.73 HansaBiomed
6.74 HeiScreen
6.75 Helomics
6.76 Horizon Discovery
6.77 HTG Molecular Diagnostics
6.78 iCellate
6.79 Illumina
6.80 Incell Dx
6.81 Inivata
6.82 Integrated Diagnostics
6.83 Invitae Corporation
6.84 Invivogen
6.85 Invivoscribe
6.86 Janssen Diagnostics
6.87 MDNA Life SCIENCES, Inc
6.88 MDx Health
6.89 Menarini Silicon Biosystems
6.90 Millipore Sigma
6.91 Miltenyi Biotec
6.92 MIODx
6.93 miR Scientific
6.94 Molecular MD
6.95 MyCartis
6.96 Myriad Genetics/Myriad RBM
6.97 NantHealth, Inc.
6.98 Natera
6.99 NeoGenomics
6.100 New Oncology
6.101 NGeneBio
6.102 Novogene Bioinformatics Technology Co., Ltd
6.103 Oncocyte
6.104 OncoDNA
6.105 Ortho Clinical Diagnostics
6.106 Oxford Nanopore Technologies
6.107 Panagene
6.108 Perkin Elmer
6.109 Personal Genome Diagnostics
6.110 Personalis
6.111 Precipio
6.112 PrecisionMed
6.113 Promega
6.114 Qiagen Gmbh
6.115 Rarecells SAS
6.116 RareCyte
6.117 Roche Molecular Diagnostics
6.118 Screencell
6.119 Sense Biodetection
6.120 Serametrix
6.121 Siemens Healthineers
6.122 Silicon Biosystems
6.123 simfo GmbH
6.124 Singlera Genomics Inc
6.125 Singulomics
6.126 SkylineDx
6.127 Stratos Genomics
6.128 Sysmex Inostics
6.129 Tempus Labs, Inc.
6.130 Thermo Fisher Scientific Inc.
6.131 Thrive Earlier Detection
6.132 Todos Medical
6.133 Trovagene
6.134 Variantyx
6.135 Volition
6.136 Vortex Biosciences
7 The Global Market for Cancer Gene Panels and Profiles
7.1 Global Market Overview by Country
7.1.1 Table - Global Market by Country
7.1.2 Chart - Global Market by Country
7.2 Global Market by Cancer Type - Overview
7.2.1 Table - Global Market by Cancer Type
7.2.2 Chart - Global Market by Cancer Type - Base/Final Year Comparison
7.2.3 Chart - Global Market by Cancer Type - Base Year
7.2.4 Chart - Global Market by Cancer Type - Final Year
7.2.5 Chart - Global Market by Cancer Type - Share by Year
7.2.6 Chart - Global Market by Cancer Type - Segment Growth
7.3 Global Market by Application - Overview
7.3.1 Table - Global Market by Application
7.3.2 Chart - Global Market by Application - Base/Final Year Comparison
7.3.3 Chart - Global Market by Application - Base Year
7.3.4 Chart - Global Market by Application - Final Year
7.3.5 Chart - Global Market by Application - Share by Year
7.3.6 Chart - Global Market by Application - Segment Growth
7.4 Global Market by Tissue - Overview
7.4.1 Table - Global Market by Tissue
7.4.2 Chart - Global Market by Tissue - Base/Final Year Comparison
7.4.3 Chart - Global Market by Tissue - Base Year
7.4.4 Chart - Global Market by Tissue - Final Year
7.4.5 Chart - Global Market by Tissue - Share by Year
7.4.6 Chart - Global Market by Tissue - Segment Growth
7.5 Global Market Germline & Somatic - Overview
7.5.1 Table - Global Market Germline & Somatic
7.5.2 Chart - Global Market Germline & Somatic - Base/Final Year Comparison
7.5.3 Chart - Global Market Germline & Somatic - Base Year
7.5.4 Chart - Global Market Germline & Somatic - Final Year
7.5.5 Chart - Global Market Germline & Somatic - Share by Year
7.5.6 Chart - Global Market Germline & Somatic - Segment Growth
8 Global Cancer Gene Panels & Profiles Markets - By Type of Cancer
8.1 Comprehensive Panels & Profiles
8.1.1 Table Comprehensive Testing - by Country
8.1.2 Chart - Comprehensive Testing Growth
8.2 Breast Cancer Gene Testing
8.2.1 Table Breast Cancer Gene Testing - by Country
8.2.2 Chart - Breast Cancer Testing Growth
8.3 Colorectal Cancer Gene Testing
8.3.1 Table Colorectal Cancer Gene Testing - by Country
8.3.2 Chart - Colorectal Cancer Gene Testing Growth
8.4 Gynecological Cancer Gene Testing
8.4.1 Table Gynecological Cancer Gene Testing - by Country
8.4.2 Chart - Gynecological Cancer Gene Testing Growth
8.5 Blood Cancer Gene Testing
8.5.1 Table Blood Cancer Gene Testing - by Country
8.5.2 Chart - Blood Cancer Gene Testing Growth
8.6 Prostate Cancer Gene Testing
8.6.1 Table Prostate Cancer Gene Testing - by Country
8.6.2 Chart - Prostate Cancer Testing Growth
8.7 Lung Cancer Gene Testing
8.7.1 Table Lung Cancer Gene Testing - by Country
8.7.2 Chart - Lung Cancer Gene Testing Growth
8.8 Other Cancer Gene Testing
8.8.1 Table Other Cancer Gene Testing - by Country
8.8.2 Chart - Other Cancer Gene Testing Growth
9 Global Cancer Gene Panels & Profiles Markets - By Type of Application
9.1 Clinical Testing
9.1.1 Table Clinical Testing - by Country
9.1.2 Chart - Clinical Testing Growth
9.2 Pharmaceutical Testing
9.2.1 Table Pharmaceutical Testing - by Country
9.2.2 Chart - Pharmaceutical Testing Growth
9.3 Research Testing
9.3.1 Table Research Testing - by Country
9.3.2 Chart - Research Testing Growth
10 Global Cancer Gene Panels & Profiles Markets - By Tissue Type
10.1 Solid Tissue
10.1.1 Table Solid Tissue Testing - by Country
10.1.2 Chart - Solid Tissue Testing Growth
10.2 Liquid Tissue Testing
10.2.1 Table Liquid Tissue Testing - by Country
10.2.2 Chart - Liquid Tissue Testing Growth
11 Global Cancer Gene Testing Markets - Germline and Somatic
11.1 Global Market Somatic
11.1.1 Table Somatic - by Country
11.1.2 Chart - Somatic Testing Growth
11.2 Global Market Germline
11.2.1 Table Germline - by Country
11.2.2 Chart - Germline Testing Growth
12 Potential Market Opportunity Sizes
12.1 Potential Cancer Screening by Country: Lung, Breast & Colorectal
12.2 Potential Cancer Screening by Country: Prostate, Other Cancer & All Cancer
12.3 Potential Market Size - Cancer Diagnosis
12.4 Potential Market Size - Therapy Selection
13 Appendices
13.1 Quarterly Actuals and Forecast Volumes and Revenues for Foundation Medicine and Guardant Health
13.2 United States Medicare System: January 2022 Clinical Laboratory Fees Schedule
13.3 FDA Approved Human Genetic Tests
13.4 Pharmacogenomic Biomarkers in Drug Labeling
13.5 FDA Approved Pharmacogenomics Tests
Table of Tables
Table 1 Market Shares
Table 2 Market Players by Type
Table 3 The Base Pairs
Table 4 Current Assays
Table 5 Relevant Pricing Table
Table 6 Five Factors Driving Growth
Table 7 Four Factors Limiting Growth
Table 8 Key Diagnostic Laboratory Technology Trends
Table 9 Next Generation Sequencing Technologies - Speed and Cost
Table 10 - Global Cancer Panel Market by Region
Table 11 Global Market by Cancer Type
Table 12 Global Market by Application
Table 13 Global Market by Tissue
Table 14 Global Market Germline & Somatic
Table 15 Comprehensive Testing by Country
Table 16 Breast Cancer Gene Testing by Country
Table 17 Colorectal Cancer Gene Testing by Country
Table 18 Gynecological Cancer Testing by Country
Table 19 Blood Cancer Gene Testing by Country
Table 20 Prostate Cancer Gene Testing by Country
Table 21 Lung Cancer Gene Testing by Country
Table 22 Other Cancer Gene Testing by Country
Table 23 Clinical Testing by Country
Table 24 Pharmaceutical Testing by Country
Table 25 Research Testing by Country
Table 26 Solid Tissue Testing by Country
Table 27 Liquid Tissue Testing by Country
Table 28 Somatic by Country
Table 29 Germline by Country
Table 30 Potential Screening Market: Lung, Breast & Colorectal
Table 31 Potential Screening Market: Prostate, Other & All
Table 32 Potential Cancer Diagnosis Market Size
Table 33 Potential Cancer Management Market Size
Table 34 Foundation - Guardant 2016-17 Quarterly Revenue & Volume
Table 35 Foundation - Guardant 2018 Quarterly Revenue & Volume
Table 36 Foundation - Guardant 2019 Quarterly Revenue & Volume
Table 37 Foundation - Guardant 2020 Quarterly Revenue & Volume
Table 38 Foundation - Guardant 2021 Quarterly Revenue & Volume
Table 39 2022 Laboratory Fee Schedule
Table 40 FDA Approved Human Genetic tests
Table 41 Pharmacogenomic Biomarkers
Table 42 FDA Approved Pharmacogenomic Tests
List of Figures
Figure 1 Large Comprehensive Profiles - Company Market Shares Chart
Figure 2 VistSeq Hereditary Cancer Panel
Figure 3 Global Healthcare Spending
Figure 4 The Wholesale and Retail Lab Test Pie
Figure 5 The Genomic Progression of Cancer
Figure 6 DNA Strands and Chromosomes
Figure 7 Karyogram of Human Chromosomes
Figure 8 Size of Various Genomes
Figure 9 Germline vs Somatic Mutations
Figure 10 Comparing Genomic Diagnostic and Traditional Testing
Figure 11 Percentage of World Population Over 65
Figure 12 Base Year Country Global Share
Figure 13 Global Market by Cancer - Base vs. Final Year
Figure 14 Cancer Panel Market Base Year
Figure 15 Cancer Panel Market Final Year
Figure 16 Cancer Type Share by Year
Figure 17 Cancer Type Segment Growth
Figure 18 Global Market by Cancer - Base vs. Final Year
Figure 19 Cancer Panel Market Base Year
Figure 20 Cancer Panel Market Final Year
Figure 21 Application Share by Year
Figure 22 Application Segment Growth
Figure 23 Global Market by Cancer - Base vs. Final Year
Figure 24 Cancer Panel Market Base Year
Figure 25 Cancer Panel Market Final Year
Figure 26 Tissue Share by Year
Figure 27 Tissue Segment Growth
Figure 28 Germline & Somatic - Base vs. Final Year
Figure 29 Germline & Somatic Market Base Year
Figure 30 Germline & Somatic Market Final Year
Figure 31 Germline & Somatic Share by Year
Figure 32 Germline & Somatic Segment Growth
Figure 33 Comprehensive Testing Growth
Figure 34 Breast Cancer Testing Growth
Figure 35 Colorectal Cancer Gene Testing Growth
Figure 36 Gynecological Cancer Testing Growth
Figure 37 Blood Cancer Gene Testing Growth
Figure 38 Prostate Cancer Gene Testing Growth
Figure 39 Lung Cancer Gene Testing Growth
Figure 40 Other Cancer Gene Testing Growth
Figure 41 Clinical Testing Growth
Figure 42 Pharmaceutical Testing Growth
Figure 43 Research Testing Growth
Figure 44 Solid Tissue Testing Growth
Figure 45 Liquid Tissue Testing Growth
Figure 46 Somatic Testing Growth
Figure 47 Germline Testing Growth

Companies Mentioned

  • 10x Genomics, Inc.
  • Abbott Diagnostics
  • AccuraGen Inc.
  • Adaptive Biotechnologies
  • Aethlon Medical
  • Agena Bioscience, Inc.
  • Agilent/Dako
  • Anchor Dx
  • ANGLE plc
  • ApoCell, Inc.
  • ArcherDx, Inc.
  • ARUP Laboratories
  • Asuragen
  • AVIVA Biosciences
  • Baylor Miraca Genetics Laboratories
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • BGI Genomics Co. Ltd
  • Bioarray Genetics
  • Biocartis
  • Biocept, Inc
  • Biodesix Inc
  • BioFluidica
  • BioGenex
  • BioIVT
  • Biolidics Ltd
  • bioMérieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc
  • Bio-Reference Laboratories
  • Bio-Techne
  • Bioview
  • Bolidics
  • Boreal Genomics
  • Bristol-Myers Squibb
  • Burning Rock
  • Cancer Genetics
  • Caris Molecular Diagnostics
  • Castle Biosciences, Inc.
  • Celemics
  • CellMax Life
  • Cepheid (Danaher)
  • Charles River Laboratories
  • Chronix Biomedical
  • Circulogene
  • Clinical Genomics
  • Cynvenio
  • Cytolumina Technologies Corp.
  • CytoTrack
  • Datar Cancer Genetics Limited
  • Diagnologix LLC
  • Diasorin S.p.A.
  • Enzo Life Sciences, Inc
  • Epic Sciences
  • Epigenomics AG
  • Eurofins Scientific
  • Exact Sciences
  • Exosome Diagnostics
  • Exosome Sciences
  • Fabric Genomics
  • Fluidigm Corp
  • Fluxion Biosciences
  • Foundation Medicine
  • Freenome
  • FUJIFILM Wako Diagnostics
  • GeneFirst Ltd
  • Genetron Holdings
  • GenomOncology
  • GILUPI Nanomedizin
  • Grail, Inc.
  • Guardant Health
  • HalioDx
  • HansaBiomed
  • HeiScreen
  • Helomics
  • Horizon Discovery
  • HTG Molecular Diagnostics
  • iCellate
  • Illumina
  • Incell Dx
  • Inivata
  • Integrated Diagnostics
  • Invitae Corporation
  • Invivogen
  • Invivoscribe
  • Janssen Diagnostics
  • MDNA Life SCIENCES, Inc
  • MDx Health
  • Menarini Silicon Biosystems
  • Millipore Sigma
  • Miltenyi Biotec
  • MIODx
  • miR Scientific
  • Molecular MD
  • MyCartis
  • Myriad Genetics/Myriad RBM
  • NantHealth, Inc.
  • Natera
  • NeoGenomics
  • New Oncology
  • NGeneBio
  • Novogene Bioinformatics Technology Co., Ltd
  • Oncocyte
  • OncoDNA
  • Ortho Clinical Diagnostics
  • Oxford Nanopore Technologies
  • Panagene
  • Perkin Elmer
  • Personal Genome Diagnostics
  • Personalis
  • Precipio
  • PrecisionMed
  • Promega
  • Qiagen Gmbh
  • Rarecells SAS
  • RareCyte
  • Roche Molecular Diagnostics
  • Screencell
  • Sense Biodetection
  • Serametrix
  • Siemens Healthineers
  • Silicon Biosystems
  • simfo GmbH
  • Singlera Genomics Inc
  • Singulomics
  • SkylineDx
  • Stratos Genomics
  • Sysmex Inostics
  • Tempus Labs, Inc.
  • Thermo Fisher Scientific Inc.
  • Thrive Earlier Detection
  • Todos Medical
  • Trovagene
  • Variantyx
  • Volition
  • Vortex Biosciences

Methodology

Loading
LOADING...